Psychedelics Definium Therapeutics soars on Phase 3 trial win with LSD depression drug The rally follows year-to-date gains of nearly 175% Rowan Dunne4 days ago
Bitcoin The year 2025 in review: A Mugglehead roundup Innovation created new avenues for wealth creation, but also exposed structural weaknesses and human error Joseph MortonDecember 30, 2025
Psychedelics Incannex orders psilocybin and MDMA from PharmAla Biotech Incannex plans to open a series of psychedelics clinics in Australia and use PharmAla's products Rowan DunneApril 25, 2023
Canada PsyCan aims to be ‘go-to’ psychedelics industry organization, receives support from lawmakers The non-profit trade association received a high level of interest from multiple branches of government Rowan DunneNovember 10, 2022